Paper published in a journal (Scientific congresses and symposiums)
Characterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist
Hanson, Julien; Rolin, S.; De Leval, X. et al.
2004In Fundamental and Clinical Pharmacology, p. 269
Peer Reviewed verified by ORBi
 

Files


Full Text
Fund. Clin. Pharm. 2004, 18, 269-271.pdf
Publisher postprint (88.61 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Hanson, Julien  ;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Rolin, S.
De Leval, X.
Neven, P.
Masereel, B.
Pirotte, Bernard ;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Dogné, Jean-Michel ;  Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Language :
English
Title :
Characterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist
Publication date :
2004
Audience :
International
Journal title :
Fundamental and Clinical Pharmacology
ISSN :
0767-3981
eISSN :
1472-8206
Publisher :
Blackwell Science, Oxford, United Kingdom
Special issue title :
18
Pages :
269
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 11 September 2009

Statistics


Number of views
43 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi